Kajian Pengobatan Dengue Haemoragic Fever (DHF) di Rumah Sakit Pendidikan Universitas Mataram
DOI:
https://doi.org/10.31764/lf.v4i1.8382Keywords:
Dengue Heamoraggic Fever(DHF), rasionality, therapyAbstract
Dengue Hemorrhagic Fever (DHF) has become a worldwide problem. Dengue Haemoraggic Fever (DHF) is a disease caused by the dengue virus through the bite of the Aedes aegypti mosquito. DHF has a high mortality rate, so there is a need for appropriate therapy to reduce morbidity. This study aims to determine how the rationality of treatment in patients with Dangue Haemorraggic Fever (DHF) at the University Hospital of Mataram for the Period January - June 2020. This study is a non-experimental descriptive study, where data was taken retrospectively obtained from records. Medical records of Dengue Haemoraggic Fever (DHF) patients at the Inpatient Installation of Mataram University Hospital Period January - June 2020. The sampling technique used was purposive sampling, and 40 medical records were obtained. This research was conducted by looking at the rationality of treatment based on the right indication, the right patient, the right drug, and the right dose. The data obtained were compared with the basic guidelines for the management of DHF treatment therapy from the Ministry of Health of the Republic of Indonesia in 2004. The results showed the rationality of DHF treatment seen from several aspects, namely in the use of analgesic-antipyretic drugs and maintenance fluids, appropriate indications in the use of analgesic-antipyretic drugs and maintenance fluid obtained a percentage of 100%. In addition, the exact data on antipyretic analgesic drugs was 82.5%, the exact dose of antipyretic analgesics was 55%References
Andriani N.W.E., Tjitrosantoso H dan Paulina V.Y Yamlean. Kajian Penatalaksanaan Terapi Pengobatan Demam Berdarah Dengue (Dbd) Pada Penderita Anak Yang Menjalani Perawatan Di Rsup Prof. Dr. R.D Kandou Tahun 2013. Program Studi Farmasi FMIPA UNSRAT Manado, Vol. 3 No. 2 Mei 2014.
Departemen Kesehatan R. Tata Laksana Demam Berdarah Dengue, hal: 1-62, Jakarta: Depkes RI. 2004.
Ginanjar G.,. Demam Berdarah : A Survival Guide, P.2-30, Yogyakarta First PT Benteng Pustaka. 2008.
Herdman, T Heather. Diagnose Keperawatan: Definisi dan Klasifikasi 2012- 2014. Dialihbahasakan oleh Made Sumarwati dan Nike Budhi Subekti. Barrarah Bariid, Monica Ester, dan Wuri Praptiani (ed). Jakarta: EGC. 2012.
Hukom A.O.E, Warouw S.M, Memah M dan Mongan A.E. Hubungan Nilai Hematokrit Dan Nilai Jumlah Trombosit Pada Pasien Demam Berdarah Dengue. Jurnal e-Biomedik (eBM), Volume 1:707-711. 2013.
Joseph I, Bahrun U, Ganda I.J, Arif M., 2011. Imunoglobulin A Di Demam Berdarah Dengue.Vol. 18, No. 1 November 2011.
Juranah, Muhadi D, Arif M dan Bahar B., 2011. Uji Hematologi Pasien Terduga Demam Berdarah Dengue Indikasi Rawat Inap, Vol. 17, No. 3, Juli 2011: hal: 139–142. 2011.
Karyanti, M. R. Pemeriksaan Diagnostik Terkini Untuk Demam Tifoid. In: S. R. hadinegoro, et al. eds. Update Management of Infectious Disease And Gastorintestinal Disorders. Jakarta: Departemen Ilmu Kesehatan Anak FKUI-RSCM, pp. 1-7. 2012.
Kementrian Kesehatan RI. Demam Berdarah Biasanya Mulai Meningkat di Januari. Jakarta: Direktorat Jendral Pengendalian Penyakit & Penyehatan Lingkungan. 2015.
Lestari, K. Epidemiologi Dan Pencegahan Demam Berdarah Dengue(DBD) Di Indonesia, Farmaka, Vol. 5 No. 3, Desember 2007 hal : 12-29. 2007.
Rachmawati L. Isolasi, Identifikasi Dan Uji Aktivitas Antioksidan Senyawa Flavonoid Daunbinahong (Anredera Cordifolia (Ten.) Steenis). Semarang: Fakultas Sains dan Matematika Universitas Diponegoro. 2012.
Rasyada A, Nasrul E, Edward Z. Hubungan Nilai Hematokrit terhadap jumlah trombosit pada penderita demam berdarah dengue. Jurnal Kesehatan Andalas, 3(3): 344-345. 2014.
Rohmani A dan Anggraini M.T. Pemakaian Antibiotik Pada Kasus Demam Berdarah Dengue Anak Di Rumah Sakit Roemani Semarang Tahun 2010. Semarang: Fakultas Kedokteran, Universitas Muhammadiyah Semarang. 2012.
Setiyaningrum. Evaluasi penatalaksanaan Terapi Penyakit Demam Berdarah Dengue (DBD) pada Pasien Anak di Instalasi Rawat Inap RS. Roemani Muhammadyah Semarang tahun 2009. Surakarta: Fakultas Farmasi. Universitas Muhammadyah Surakarta. 2010.
Setyaningrum N.M.A. Pola Pengobatan Demam Berdarah Dengue (DBD) Di Instalasi Rawat Inap Rumah Sakit Islam Sultan Agung Semarang Periode Agustus 2015-Maret 2016. Semarang Program Studi Ilmu Farmasi, Sekolah Tinggi Ilmu Kesehatan Ngudi Waluyo Ungaran. 2016.
World Health Organization. National Guidelines for Clinical Management of Dengue Fever, Revised and Expanded Edition, India, World Health Organization. 2015.
